These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14996674)

  • 1. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.
    Juul K; Tybjaerg-Hansen A; Schnohr P; Nordestgaard BG
    Ann Intern Med; 2004 Mar; 140(5):330-7. PubMed ID: 14996674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
    Middeldorp S; Meinardi JR; Koopman MM; van Pampus EC; Hamulyák K; van Der Meer J; Prins MH; Büller HR
    Ann Intern Med; 2001 Sep; 135(5):322-7. PubMed ID: 11529695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. Blood clots in people with factor V Leiden mutation.
    Ann Intern Med; 2004 Mar; 140(5):I50. PubMed ID: 14996692
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor V leiden homozygosity, dyspnea, and reduced pulmonary function.
    Juul K; Tybjaerg-Hansen A; Mortensen J; Lange P; Vestbo J; Nordestgaard BG
    Arch Intern Med; 2005 Sep; 165(17):2032-6. PubMed ID: 16186475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
    Spannagl M; Heinemann LA; Schramm W
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
    Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study.
    Zöller B; Melander O; Svensson PJ; Engström G
    Vasc Med; 2018 Feb; 23(1):52-59. PubMed ID: 29320959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
    Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
    Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
    Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR
    Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
    Procare Group
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):523-9. PubMed ID: 12960604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.
    Arsov T; Miladinova D; Spiroski M
    Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study.
    Klovaite J; Benn M; Nordestgaard BG
    J Intern Med; 2015 May; 277(5):573-84. PubMed ID: 25161014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.